Evidence map›Paper›PMID 34085541›Full record

ArticleAnnals of Saudi medicine

Hearing loss among patients with type 2 diabetes mellitus: a cross-sectional study.

Khalid Al-Rubeaan, Murad AlMomani, Aisha Khalaf AlGethami, Jamal Darandari, Abdulaziz Alsalhi, Dehkra AlNaqeeb, Ebtehal Almogbel, Fatima H Almasaari, Amira M Youssef

Open access · diamondAbstract read
In one paragraph

Article in Annals of Saudi medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Characteristics of Hearing Loss in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2025
    Pooled it
  2. Type 2 Diabetes Mellitus and Hearing Loss: A Prisma Systematic Review and Meta-Analysis.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2025
    Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Repercussions of Hearing in Gestational Diabetes Patients.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Audiological profile of patients with type 2 diabetes mellitus.The South African journal of communication disorders = Die Suid-Afrikaanse tydskrif vir Kommunikasieafwykings · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Diabetes mellitus and hearing loss.Molecular medicine (Cambridge, Mass.) · 2023
    Review
  18. Evaluation of the Effects of Dyslipidemia on Hearing in Patients with Type 2 Diabetes Mellitus.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2023
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Khalid Al-RubeaanFrom the Research and Scientific Center, Sultan Bin Abdulaziz Humanitarian City; Riyadh, Saudi Arabia.
Murad AlMomaniFrom the Department of ENT, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Aisha Khalaf AlGethamiFrom the Family Medicine Department, King Abdulaziz Specialist Hospital, Taif, Saudi Arabia.
Jamal DarandariFrom the Department of Family Medicine, Prince Sultan Military Hospital, Taif, Saudi Arabia.
Abdulaziz AlsalhiFrom the Research and Scientific Center, Sultan Bin Abdulaziz Humanitarian City; Riyadh, Saudi Arabia.
Dehkra AlNaqeebFrom the Research Department, King Saud University, Riyadh, Saudi Arabia.
Ebtehal AlmogbelFrom the Department of Family and Community Medicine, College of Medicine, Qassim University, Qassim, Saudi Arabia.
Fatima H AlmasaariFrom the University Diabetes Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Amira M YoussefFrom the Department of Registry, King Saud University, Riyadh, Saudi Arabia.
King Saud University · SAKing Abdulaziz Hospital · SAQassim University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHearing loss is an underestimated comorbid condition in type 2 diabetes.

objectivesInvestigate hearing loss as a comorbidity associated with type 2 diabetes mellitus and evaluate the factors associated with hearing loss.

designCross-sectional.

settingTertiary care center, diabetes clinic. PATIENTS AND

methodsPatients with type 2 diabetes, aged 30 to 60 years, were randomly selected to participate. All patients underwent clinical ear examinations and were referred for full audiological evaluation. Otoacoustic emission was used to assess inner function, tympanometry to assess middle-ear function, and pure tone air/bone audiometry to assess hearing sensitivity. Risk factors for hearing loss were assessed by multivariate logistic regression.

main outcome measureFrequency, severity and risk factors for hearing loss. SAMPLE SIZE: 157

resultsOf the 157 patients, 77 had hearing loss in both ears (49.0%), 13 in the right ear only (8.3%), 14 in the left ear only (8.9%), and 53 (33.8%) had normal hearing. In the 181 ears with sensorineural hearing loss, 90 had mild loss (49.7%), 69 moderate loss (38.2%), 16 severe loss (8.8%) and 6 had profound loss (3.3%). Disabling hearing loss was observed in 46 (29%) patients. A higher frequency of hearing loss was present in patients with glycated hemoglobin levels ≥8%. In the multivariate logistic regression analysis, the most important factors associated with hearing loss were longer diabetes duration, poor glycemic control and the presence of hypertension.

conclusionsHearing loss is an underestimated comorbid condition in type 2 diabetes that warrants frequent hearing assessments and management. Strict glycemic and hypertension control is essential for the minimization of the effects of diabetes on hearing sensitivity. LIMITATIONS: Small sample size, limited age window (30-60 years), which was chosen to eliminate the natural aging effect on hearing. Cross-sectional nature was not ideal for the assessment of causality. CONFLICT OF INTEREST: None.

Indexed as

Diabetes Mellitus, Type 2Hearing LossAdultAudiometry, Pure-ToneCross-Sectional StudiesHumansMiddle AgedOtoacoustic Emissions, Spontaneous

Identifiers

PMID34085541
PMCPMC8176373
OpenAlexW3164219941

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.